SGLT2 INHIBITORS IN CLINICAL TRIALS Pages on BioPortfolio:

BioPortfolio - SGLT2 INHIBITORS IN CLINICAL TRIALS
Recent Search Terms used to find this page: bardoxolone effects | Bardoxolone Methyl | bardoxolone methyl | SGLT2 INHIBITORS IN CLINICAL TRIALS | Glomerulus ...
http://www.bioportfolio.com/search/SGLT2_INHIBITORS_IN_CLINI...

BioPortfolio - nephron pharmaceuticals
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science ... methyl | SGLT2 INHIBITORS IN CLINICAL TRIALS | Glomerulus | VA NEPHRON-D | . ...
http://www.bioportfolio.com/search/nephron_pharmaceuticals.h...

BioPortfolio - Kidney Glomerulus
Kidney Glomerulus Clinical Trials:. Clinical Trials Logo ... 6610693, Fructosamine oxidase: antagonists and inhibitors ...
http://www.bioportfolio.com/indepth/Kidney_Glomerulus.html...

BioPortfolio - Kidney Glomerulus - InDepth
Kidney Glomerulus Clinical Trials: ... 6555519- O-glucosylated benzamide SGLT2 inhibitors and method. • 6562371- Liposomes ...
http://www.bioportfolio.com/indepth/Kidney_Glomerulus.pdf...

BioPortfolio - Kissei Pharmaceutical Corporation - Profile
Cotransporter (SGLT2) Inhibitors, Exhibits Antidiabetic Efficacy in .... information resources: publications, clinical trials, patents and global news. ...
http://www.bioportfolio.com/biocorporate/6125-Kissei+Pharmac...

BioPortfolio - Hyperinsulinemia - InDepth
Hyperinsulinemia Clinical Trials:. • Utility of [F-18] fluoroDOPA for Neonatal ... 7375213- Methods of producing C-aryl glucoside SGLT2 inhibitors ...
http://www.bioportfolio.com/indepth/Hyperinsulinemia.pdf...

BioPortfolio - Bristol-Myers Squibb - Profile
7375213- Methods of producing C-aryl glucoside SGLT2 inhibitors ... information resources: publications, clinical trials, patents and global news. ...
http://www.bioportfolio.com/biocorporate/20048-Bristol-Myers...

BioPortfolio - Kidney Cortex - InDepth
Kidney Cortex Clinical Trials:. • Epidural Cortical Stimulation for Depression ... 7375213- Methods of producing C-aryl glucoside SGLT2 inhibitors ...
http://www.bioportfolio.com/indepth/Kidney_Cortex.pdf...

BioPortfolio - TES - testis derived transcript (3 LIM domains)
International Multi Centre Randomized Clinical Trial Of Anticoagulation In Children ... 7375213, Methods of producing C-aryl glucoside SGLT2 inhibitors ...
http://www.bioportfolio.com/gene/26136-TES.html...

BioPortfolio - Hypertriglyceridemia - InDepth
Hypertriglyceridemia Clinical Trials:. • Effect of Soluble Fiber on Hypertriglyceridemia ... 7375213- Methods of producing C-aryl glucoside SGLT2 inhibitors ...
http://www.bioportfolio.com/indepth/Hypertriglyceridemia.pdf...

Results from other life science and pharmaceutical sites:

SGLT2 Inhibitors for the Treatment of Diabetes
Increased urinary sodium excretion has been seen with SGLT2 inhibitors and is ... The results of longer-term clinical trials of safety and efficacy will ...
http://www.medscape.com/viewarticle/578176...

cd-778718 Review Sodium-glucose cotransporter inhibitors for ...
Several companies are developing SGLT2 inhibitors, and some of these compounds have progressed to clinical trials (Table 2). SGLT1 plays an important role ...
http://www.biomedcentral.com/content/download/xml/cd-778718....

Sodium-Glucose Transporter 2 Inhibitors
31 Jul 2008 ... Medscape: What SGLT2 inhibitors are in clinical development now? ... Dr. Henry: The clinical trial was conducted in 389 treatment-naive ...
http://www.medscape.com/viewarticle/578174...

(August 5, 2002) | Takeda Pharmaceutical Company Limited
In U.S., Kissei's subsidiary, Kissei Pharma U.S.A. is conducting phase II clinical trials. 4) SGLT2 Selective Inhibitor This agent inhibits the activity
of ...
http://www.takeda.com/press/article_672.html...

Sodium-Glucose Transporter 2 Inhibitors
Only assessment in the context of clinical trials (controlling for hyperglycemia with an active comparator) will tell us whether SGLT2 inhibitors increase ...
http://www.medscape.com/viewarticle/572084_5...

Microsoft PowerPoint - sigal_strategy_pdf.ppt
Clinical Discovery. Clinical Research. Development Operations. Medical Affairs. Regulatory .... SGLT2 Inhibitor (Diabetes). (Diabetes). • Inhaled Insulin ...
http://www.bms.com/investors/speeches_and_events/content/dat...

Patent selection
Kissei and GlaxoSmithKline are developing. the SGLT2 inhibitor KGT-1251 (in phase I clinical trials) as a. potential therapeutic in type 2 diabetes. ...
http://www.biomedcentral.com/content/pdf/cd-548022.pdf...

Product Development Pipeline February
SGLT2 inhibitor. type 2 diabetes ..... successfully meeting the date assuming the clinical data meets the expected end-points of the clinical trials. ...
http://www.gsk.com/investors/product_pipeline/docs/gsk-pipel...

Microsoft PowerPoint - gregg_pdf.ppt
SGLT2 Inhibitor (Diabetes). (Diabetes). • Inhaled Insulin. Inhaled Insulin ( Diabetes). (Diabetes) .... American Society of Clinical Oncology, June 2004 ...
http://www.bms.com/investors/speeches_and_events/content/dat...

Product Development Pipeline September
SGLT2 inhibitor. type 2 diabetes. ll. Syncria (albiglutide) ..... data meets the expected end-points of the clinical trials. ...
http://www.gsk.com/investors/product_pipeline/docs/gsk-pipel...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.